Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2020 1
2021 2
2022 1
2023 3
2024 2
2025 3

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

10 results

Results by year

Filters applied: . Clear all
Page 1
Did you mean rejmankova e (40 results)?
Tolebrutinib versus Teriflunomide in Relapsing Multiple Sclerosis.
Oh J, Arnold DL, Cree BAC, Ionete C, Kim HJ, Sormani MP, Syed S, Chen Y, Maxwell CR, Benoit P, Turner TJ, Wallstroem E, Wiendl H; Tolebrutinib Phase 3 GEMINI 1 and 2 Trial Group. Oh J, et al. N Engl J Med. 2025 May 15;392(19):1893-1904. doi: 10.1056/NEJMoa2415985. Epub 2025 Apr 8. N Engl J Med. 2025. PMID: 40202623 Clinical Trial.
Four years on: Pregnancy and birth outcomes reported in the MSBase pregnancy, neonatal outcomes, and Women's Health Registry (2020-2024).
Jokubaitis VG, Alroughani R, Altintas A, Eichau S, Hughes S, Willekens B, Horakova D, Havrdova EK, Ozakbas S, Boz C, Habek M, Kalincik T, Roos I, Etemadifar M, Peterka M, Lechner-Scott J, Meca-Lallana JE, Rous Z, Houskova J, Prat A, Girard M, Ampapa R, Buzzard K, Skibina O, John NA, Kermode AG, Fabis-Pedrini MJ, Foschi M, Surcinelli A, Blanco Y, Baghbanian SM, Gerlach O, Macdonell R, Pavelek Z, Stourac P, McCombe P, Laureys G, Butzkueven H, van der Walt A, Gray O; MSBase Study Investigators. Jokubaitis VG, et al. Mult Scler. 2025 Aug;31(9):1088-1101. doi: 10.1177/13524585251349125. Epub 2025 Jul 7. Mult Scler. 2025. PMID: 40621862 Free PMC article.
Pregnancy-Related Disease Outcomes in Women With Moderate to Severe Multiple Sclerosis Disability.
Shipley J, Beadnall HN, Sanfilippo PG, Yeh WZ, Horakova D, Havrdova EK, Hradilek P, Kalincik T, Roos I, Prat A, Girard M, Rous Z, Pavelek Z, Gerlach OHH, Lechner-Scott J, Alroughani R, Ozakbas S, Peterka M, Buzzard K, Skibina OG, Maimone D, Foschi M, Surcinelli A, Karabudak R, Spitaleri DLA, Lugaresi A, Tomassini V, Gouider R, Mrabet S, Ferrando BR, Hodgkinson S, Štourac P, Guimarães J, John NA, Macdonell RAL, Meca-Lallana JE, Butzkueven H, van der Walt A, Jokubaitis VG; MSBase Investigator Group. Shipley J, et al. JAMA Netw Open. 2025 Sep 2;8(9):e2531581. doi: 10.1001/jamanetworkopen.2025.31581. JAMA Netw Open. 2025. PMID: 40952740 Free PMC article.
Is breastfeeding in MS harmful or not? An answer from real-world Czech data.
Hradilek P, Zapletalova O, Hanulikova P, Havrdova EK, Woznicova I, Mazouchova A, Drahota J, Lauer M, Stetkarova I, Valis M, Libertinova J, Stourac P, Adamkova J, Ampapa R, Vachova M, Dufek M, Martinková A, Peterka M, Recmanova E, Mares J, Horakova D. Hradilek P, et al. Among authors: recmanova e. Mult Scler Relat Disord. 2023 Aug;76:104790. doi: 10.1016/j.msard.2023.104790. Epub 2023 Jun 16. Mult Scler Relat Disord. 2023. PMID: 37348317
Analysis of the Group of Pediatric Patients With Relapsing-Remitting Multiple Sclerosis: Data From the Czech National Registry.
Vališ M, Pavelek Z, Novotný M, Klímová B, Šarláková J, Halúsková S, Peterka M, Štětkárová I, Štourač P, Mareš J, Hradílek P, Ampapa R, Vachová M, Recmanová E, Meluzínová E. Vališ M, et al. Among authors: recmanova e. Front Neurol. 2022 Apr 18;13:851426. doi: 10.3389/fneur.2022.851426. eCollection 2022. Front Neurol. 2022. PMID: 35518208 Free PMC article.
Multiple sclerosis, neuromyelitis optica spectrum disorder and COVID-19: A pandemic year in Czechia.
Stastna D, Menkyova I, Drahota J, Mazouchova A, Adamkova J, Ampapa R, Grunermelova M, Peterka M, Recmanova E, Rockova P, Rous M, Stetkarova I, Valis M, Vachova M, Woznicova I, Horakova D. Stastna D, et al. Among authors: recmanova e. Mult Scler Relat Disord. 2021 Sep;54:103104. doi: 10.1016/j.msard.2021.103104. Epub 2021 Jun 24. Mult Scler Relat Disord. 2021. PMID: 34216998 Free PMC article.
Does initial high efficacy therapy in multiple sclerosis surpass escalation treatment strategy? A comparison of patients with relapsing-remitting multiple sclerosis in the Czech and Swedish national multiple sclerosis registries.
Hrnciarova T, Drahota J, Spelman T, Hillert J, Lycke J, Kubala Havrdova E, Recmanova E, Adamkova J, Mares J, Libertinova J, Pavelek Z, Hradilek P, Ampapa R, Stetkarova I, Peterka M, Martinkova A, Stourac P, Grunermelova M, Vachova M, Dufek M, Horakova D. Hrnciarova T, et al. Among authors: recmanova e. Mult Scler Relat Disord. 2023 Aug;76:104803. doi: 10.1016/j.msard.2023.104803. Epub 2023 Jun 12. Mult Scler Relat Disord. 2023. PMID: 37329786
Real-world effectiveness of cladribine as an escalation strategy for MS: Insights from the Czech nationwide ReMuS registry.
Potuznik P, Drahota J, Horakova D, Peterka M, Mazouchova A, Matyas D, Pavelek Z, Vachova M, Recmanova E, Stetkarova I, Libertinova J, Mares J, Stourac P, Grunermelova M, Martinkova A, Adamkova J, Hradilek P, Ampapa R, Dufek M, Kubala Havrdova E, Stastna D. Potuznik P, et al. Among authors: recmanova e. J Cent Nerv Syst Dis. 2024 Jul 24;16:11795735241262743. doi: 10.1177/11795735241262743. eCollection 2024. J Cent Nerv Syst Dis. 2024. PMID: 39055049 Free PMC article.
The Czech National MS Registry (ReMuS): Data trends in multiple sclerosis patients whose first disease-modifying therapies were initiated from 2013 to 2021.
Stastna D, Drahota J, Lauer M, Mazouchova A, Menkyova I, Adamkova J, Ampapa R, Dufek M, Grunermelova M, Hradilek P, Kubala Havrdova E, Mares J, Martinkova A, Pavelek Z, Peterka M, Recmanova E, Rockova P, Stetkarova I, Stourac P, Vachova M, Horakova D. Stastna D, et al. Among authors: recmanova e. Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub. 2024 Sep;168(3):262-270. doi: 10.5507/bp.2023.015. Epub 2023 Apr 28. Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub. 2024. PMID: 37114703 Free article.
Comparison of Therapies in MS Patients After the First Demyelinating Event in Real Clinical Practice in the Czech Republic: Data From the National Registry ReMuS.
Pavelek Z, Sobíšek L, Šarláková J, Potužník P, Peterka M, Štětkárová I, Štourač P, Mareš J, Hradílek P, Ampapa R, Grünermelová M, Vachová M, Recmanová E, Angelucci F, Halúsková S, Vališ M. Pavelek Z, et al. Among authors: recmanova e. Front Neurol. 2021 Jan 12;11:593527. doi: 10.3389/fneur.2020.593527. eCollection 2020. Front Neurol. 2021. PMID: 33510704 Free PMC article.